Spectra Group Photopolymers has more than 20 years of extensive experience in the fields of photochemistry, organic synthesis chemistry and UV / EB radiation curing. The acquisition will promote the vertical integration of Formlabs and accelerate the development of materials.
Under the acquisition agreement, Formlabs will invest millions of dollars to build a new biocompatible production facility within Spectra ’s existing site. The new plant facility is an FDA registered, ISO 8 certified clean room, which is located in an ISO 13485 certified facility for dental and medical material development.
"Formlabs has paid special attention to providing reliable and accessible printing processes from the beginning. Supporting a successful printing process means rigorous engineering design and innovative material development to provide customers with a seamless end-to-end printing process. Most 3D printing The manufacturers do not have vertical integration or their own resin production channels. We believe that materials are an important part of developing new applications, workflows and disrupting industries. "
In addition to focusing on Formlabs materials, Spectra will retain some autonomy and continue to serve existing customers. The company said it will continue to cooperate with independent business development and provide support in due course.
The Formlabs Dental business is composed of a team of dental experts and will bring more dedicated products and solutions to the market to meet the growing demand for 3D printing applications and the dental field. In addition, Formlabs also launched the Form 3B dental 3D printer and materials, including surgical resins and four new shades in the Digital Dentures series.
At present, Formlabs has more than ten kinds of materials suitable for Form3B dental 3D printers, including new surgical resins and four new colors of DigitalDentures materials. Other materials such as Dental SG and Dental LT are being continuously improved through print setting adjustments.